From serendipity to pilot study and then pivotal trial: Bimatoprost topical for eyelash growth

Dermatologic Surgery

Volumn 36, Issue 5, 2010, Pages 650-651

  Cohen, Joel L ^a,b  

^a AboutSkin Dermatology and DermSurgery PC   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; PLACEBO; PROMETHAZINE; AMIDE; ANTIHYPERTENSIVE AGENT; CLOPROSTENOL; DRUG DERIVATIVE;

BIOMICROSCOPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EYELASH; HAIR COLOR; HAIR GROWTH; HUMAN; HYPOTRICHOSIS; INTRAOCULAR PRESSURE; NOTE; PILOT STUDY; PRIORITY JOURNAL; VISUAL ACUITY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AMIDES; ANTIHYPERTENSIVE AGENTS; CLOPROSTENOL; EYELASHES; HUMANS; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77951272999     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01532.x     Document Type: Note

References (2)

1. Williams RD, Cohen JS, Gross RL, et al, for the Bimatoprost Study Group. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4. Br J Ophthalmol 2008 92 : 1387 1392.
2. Yoelin S, Walt JG, Earl M. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth. Dermatol Surg 2010 36 : ■ ■.